Cytovale

Cytovale is a clinical diagnostics company advancing the early detection of sepsis. Its product, the IntelliSep® sepsis test, is a diagnostic blood test that measures a patient’s immune response to help clinicians assess the likelihood of sepsis earlier and with greater confidence and accuracy. The test is completed in ~8 minutes, following a standard blood draw. IntelliSep is the only FDA-cleared diagnostic test approved for use in adults in the Emergency Department to aid in the detection of sepsis with organ dysfunction manifesting within 3 days after testing. By providing objective, actionable information early in the care pathway, Cytovale aims to improve patient outcomes, support appropriate use of hospital resources, and enable more informed clinical decision-making.